The present invention relates to methods and devices for inhibiting fibrillation.
When a subject undergoes cardiopulmonary resuscitation (CPR) for decreased or absent cardiac contraction, arrhythmias (such as ventricular fibrillation) can occur even after initially successful defibrillation or reactivation of the cardiac cycle.
Certain embodiments of the present invention provide devices, methods and computer program products that can allow cardiac compression to be selectively delivered during cardiopulmonary resuscitation and to be timed to a desired portion of an intrinsic spontaneous cardiac cycle and/or an electrical stimulus event to inhibit arrhythmias and/or improve cardiac function.
Certain embodiments of the present invention are directed toward methods for performing chest compression during cardiopulmonary resuscitation (CPR). The methods include: (a) electrically stimulating a subject's heart during cardiopulmonary resuscitation; and (b) compressing the heart proximate at a selected time proximate to the delivery of the electrical stimulation to avoid compressing the heart during a vulnerable portion of the intrinsic cardiac cycle.
In particular embodiments, the compressing step can be initiated just before or during the electrical stimulation. The compressing step may be initiated at a time that does not overlap with the T wave portion of a spontaneous intrinsic cardiac cycle.
Other embodiments are directed toward systems for performing chest compression during cardiopulmonary resuscitation (CPR). The systems include: (a) means for electrically stimulating a subject's heart during cardiopulmonary resuscitation; and (b) means for compressing the heart at a selected time proximate to the delivery of the electrical stimulation to avoid compressing the heart during a vulnerable portion of the intrinsic cardiac cycle.
In particular embodiments, the means for compressing can be configured to compress the heart at a time that does not overlap with the T wave portion of a spontaneous intrinsic cardiac cycle. The means for compressing the heart may comprise a mechanically operated device and the system may also include means for automatically controlling the mechanically operated device to apply a mechanical compression responsive to the timing of the electrical stimulation. The device may be an external device configured to reside about a closed chest of the subject or the device may comprise an internal portion that is configured to automatically inflate and deflate to provide a minimally invasive direct cardiac massage.
Other embodiments are directed at methods for performing chest compression during cardiopulmonary resuscitation (CPR). The methods include: sensing a parameter corresponding to a measure of intrinsic spontaneous cardiac activity of a heart in a subject undergoing CPR; and compressing the heart of the subject during a non-vulnerable portion of the intrinsic cardiac based on the sensed parameter.
The compressing step may be initiated at a time that does not overlap with the T wave portion of a spontaneous intrinsic cardiac cycle. The sensing may be carried out using a sensing electrode in communication with an external defibrillator and/or an implantable defibrillator.
The compressing may be carried out by manually compressing the heart. In particular embodiments, an audible alert can be automatically generated when compression is to be initiated to direct a person to initiate manual compression. The manual compression may be a closed chest, minimally invasive massage, or an open chest manual compression. In certain embodiments the compressing may be carried out using a mechanical device and the method may include automatically controlling the device to apply the mechanical compression based on the timing of the intrinsic cardiac cycle as determined by the sensed parameter.
Still other embodiments are directed to systems for assisting in chest compression in a subject having cardiomalfunction. The systems include: (a) at least one cardiac activity sensor in communication with the heart of a subject configured to detect a cardiac activity parameter; (b) a controller in communication with the at least one sensing electrode; and (c) a power supply in communication with the controller, wherein, in operation, the at least one cardiac activity sensor transmits data to the controller regarding a spontaneous intrinsic cardiac cycle of the subject and the controller identifies a favorable time to deliver a chest compression based on the transmitted sensor data.
In particular embodiments, the controller identifies a time that does not overlap with the T wave portion of a spontaneous intrinsic cardiac cycle and may include an audible alert in communication with the controller. The controller can be configured to output an audible alert signal responsive to an identified favorable time to deliver a chest compression to the subject based on the transmitted sensor data. In particular embodiments, the system can include or cooperate with a mechanical device configured to apply chest compression at selected intervals with the controller configured to automatically actively control the timing of the compression applied by the mechanical device (whether an external or internal compression device).
Still other embodiments are directed toward computer program products for timing the delivery of cardiac compression during CPR. The computer program product includes a computer readable storage medium having computer readable program code embodied in the medium. The computer-readable program code includes computer readable program code that determines a favorable time to deliver cardiac compression to a subject to avoid a vulnerable period of a spontaneous intrinsic cardiac cycle.
In certain embodiments, the computer program product can include one or more of: (a) computer readable program code that identifies when electrical stimulation is applied to the subject and that determines the favorable time based on the time that the electrical stimulation is applied; (b) computer readable program code that receives data corresponding to the spontaneous cardiac activity of the subject in substantially real time and that determines the favorable time based on the received data; (c) computer readable program code that outputs an audible alert when a favorable cardiac compression time is determined; and (d) computer readable program code that automatically directs the activation of a mechanical compression device in response to the determined favorable time.
The foregoing and other objects and aspects of the present invention are described in greater detail in the drawings herein and the specification set forth below.
The present invention will now be described more fully hereinafter with reference to the accompanying figures, in which embodiments of the invention are shown. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Like numbers refer to like elements throughout. In the figures, certain layers, components or features may be exaggerated for clarity, and broken lines illustrate optional features or operations unless specified otherwise. In addition, the sequence of operations (or steps) is not limited to the order presented in the claims unless specifically indicated otherwise. Where used, the terms “attached”, “connected”, “contacting”, “coupling” and the like, can mean either directly or indirectly, wirelessly and/or wired, unless stated otherwise. The term “concurrently” means that the operations are carried out substantially simultaneously.
Certain embodiments of the present invention may be used during CPR to inhibit (typically prevent) cardiac tachyarrhythmia, including ventricular fibrillation, and/or to increase cardiac function. The term “CPR” as used herein means delivering cardiac compression, whether manually or mechanically and whether internally via a direct cardiac massage or externally through the chest, at the onset, during, or following a period of cardiac malfunction, typically cardiac arrest. Typically, but not always, CPR may include also ventilating or providing pulmonary assistance, whether manually or with a breathing-assist device to the subject. Subject according to the present invention can be any animal subject, typically a mammalian subject (e.g., human, canine, feline, bovine, caprine, ovine, equine, rodent, porcine, and/or lagomorph), and more typically is a human subject.
The term “mechanical compression device” includes those devices (mechanical and electromechanical) used to compress the cardiac muscle (via the chest or as a direct cardiac massage). The mechanical devices are physical devices, which may be automatically or manually deployed to operate. The automated mechanical compression devices can be used to carry out and/or supplement manual compression using a person's hands or manually operated devices, which can massage the heart (open chest, direct cardiac or heart massage) and/or push down on the closed chest (closed chest massage or “CCM”).
As is well known to those of skill in the art, the driving force for the flow of blood in the heart comes from the active contraction of the cardiac muscle. This contraction can be detected as an electrical signal. The cardiac contraction is triggered by electrical impulses traveling in a wave propagation pattern which begins at the cells of the SA node and the surrounding atrial myocardial fibers, and then traveling into the atria and subsequently passing through the AV node and, after a slight delay, into the ventricles.
As shown in
Unless extremely strong, electrical stimulation can typically only induce ventricular fibrillation during a vulnerable period of the cardiac cycle, which occurs during the T wave portion of the electrocardiogram (shown schematically in
As shown in
In certain embodiments, the compression is timed to be applied during contraction so that compression and contraction are additive, thereby increasing cardiac output. As shown in
Referring now to
In other embodiments as shown in
The cardiac activity parameter can be one or more parameters associated with the electrical activity of the heart such as provided by data from an electrocardiogram signal. In addition, or alternatively, a blood pressure measurement, thoracic impedance or other suitable measure of cardiac activity can be used. The cardiac activity parameter can be obtained from a cardiac activity sensor that may be positioned on or in the subject. In certain embodiments, the sensor can include a skin or surface mountable electrical activity electrode sensor(s) and/or an implanted sensor (typically integrated in an implantable defibrillator).
As shown in
The cardiocompression system 10 may be incorporated into existing patient monitoring or therapeutic devices or configured as a stand-alone unit that provides the timing of cardiac compression during CPR. For example, as shown in
In certain embodiments, internal automated or semi-automated suitable mechanical devices 50 that are configured to provide minimally invasive direct cardiac massage (MIDCM) can be controlled according to embodiments of the present invention. Examples of MIDCM devices are described in U.S. Pat. Nos. 6,200,280, 6,503,265, and 6,059,750, the contents of which are hereby incorporated by reference as if recited in full herein. Other direct massage devices are described in U.S. Pat. Nos. 5,582,580, 5,571,074, 5,484,391 5,683,364, 5,466,221 and 5,385,528, the contents of which are hereby incorporated by reference as if recited in full herein. Dissectors employing inflatable components are described in U.S. Pat. Nos. 5,730,756; 5,730,748; 5,716,325; 5,707,390; 5,702,417; 5,702,416; 5,694,951; 5,690,668; 5,685,826; 5,667,520; 5,667,479; 5,653,726; 5,624,381; 5,618,287; 5,607,443; 5,601,590; 5,601,589; 5,601,581; 5,593,418; 5,573,517; 5,540,711; 5,514,153; and 5,496,345. The contents of these patents are also incorporated by reference as if recited in full herein.
Examples of manual mechanical devices can be found in U.S. Pat. Nos. 3,219,031, 3,509,899, 3,896,797, and 4,397,306. Each of these patents describe devices which use a reciprocating plunger to compress a victim's chest along with a means of ventilating the victim, such as a source of pressurized oxygen or a squeeze bag. Certain hand held devices have been employed to serve both these functions. Indeed, the popular media have reported on the use of a suction cup plunger, often referred to as a “plumber's helper”, having been used to provide enhanced CPR. A past study determined that where cardiac support is provided by rhythmic chest compressions, cardiac output could be significantly improved by alternating chest compressions with chest decompressions. In this study, the chest was compressed and decompressed using a rubber plunger which alternately applied pressure and suction to the patient's chest. See Cohen, T. J., et al., “Active Compression-Decompression: A New Method of Cardiopulmonary Resuscitation”, J. Am. Med. Assoc. Vol. 267, No. 21, pp. 2916-23, 1992. This technique is known as active compression-decompression CPR (“ACD CPR”). ACD CPR is reported as being significantly more effective than conventional “compression-only” CPR. It provides both perfusion and ventilation, and can resuscitate some patients where conventional CPR and defibrillation fail. Devices capable of being used to perform ACD CPR are also described in U.S. Pat. No. 5,295,481 and European Patent Application No. 92303367.4 (Publication No. 0 509 773 A1). Each of these patents shows a device which includes a suction cup and handle. In each case, the aid giver would grab the handle and alternately press down and then pull up. The downward pressure would force air out of the lungs and blood out of the heart, while the pulling up on the handle would cause the suction cup to draw the chest upwardly to pull air into the lungs and blood into the heart. Another example of an external device 50 for providing ACR using an external beam is described in U.S. Pat. No. 5,630,789, the contents of which is incorporated by reference as if recited in full herein.
As shown in
The data 456 may include substantially real-time sensed cardiac activity 451 and/or the timing of an electrical stimulus. The processor 410 can be in communication with an automated mechanical compression device 40 and/or stimulus device 50. As will be appreciated by those of skill in the art, the operating system 452 may be any operating system suitable for use with a data processing system, such as OS/2, AIX, DOS, OS/390 or System390 from International Business Machines Corporation, Armonk, N.Y., Windows CE, Windows NT, Windows95, Windows98 or Windows2000 from Microsoft Corporation, Redmond, Wash., Unix or Linux or FreeBSD, Palm OS from Palm, Inc., Mac OS from Apple Computer, LabView, or proprietary operating systems. The I/O device drivers 458 typically include software routines accessed through the operating system 452 by the application programs 454 to communicate with devices such as I/O data port(s), data storage 456 and certain memory 414 components and/or the device 420. The application programs 454 are illustrative of the programs that implement the various features of the data processing system 405 and preferably include at least one application which supports operations according to embodiments of the present invention. Finally, the data 456 represents the static and dynamic data used by the application programs 454, the operating system 452, the I/O device drivers 458, and other software programs that may reside in the memory 414.
While the present invention is illustrated, for example, with reference to the CarioCompression Module 450 being an application program in
The I/O data port can be used to transfer information between the data processing system 405 and the closure attachment mechanism (such as for chubbed linked product) 420 or another computer system or a network (e.g., the Internet) or to other devices controlled by the processor. These components may be conventional components such as those used in many conventional data processing systems which may be configured in accordance with the present invention to operate as described herein.
While the present invention is illustrated, for example, with reference to particular divisions of programs, functions and memories, the present invention should not be construed as limited to such logical divisions. Thus, the present invention should not be construed as limited to the configuration of
The flowcharts and block diagrams of certain of the figures herein illustrate the architecture, functionality, and operation of possible implementations of selective implementation of single and dual clip closure means according to the present invention. In this regard, each block in the flow charts or block diagrams represents a module, segment, or portion of code, which comprises one or more executable instructions for implementing the specified logical function(s). It should also be noted that in some alternative implementations, the functions noted in the blocks might occur out of the order noted in the figures. For example, two blocks shown in succession may in fact be executed substantially concurrently or the blocks may sometimes be executed in the reverse order, depending upon the functionality involved.
In summary, certain embodiments of the present invention provide devices, methods and/or computer program products that can allow cardiac compression to be selectively delivered during cardiopulmonary resuscitation and to be timed to a desired portion of an intrinsic spontaneous cardiac cycle and/or an electrical stimulus event to inhibit (typically prevent) arrhythmias and/or improve cardiac function.
The foregoing is illustrative of the present invention and is not to be construed as limiting thereof. Although a few exemplary embodiments of this invention have been described, those skilled in the art will readily appreciate that many modifications are possible in the exemplary embodiments without materially departing from the novel teachings and advantages of this invention. Accordingly, all such modifications are intended to be included within the scope of this invention as defined in the claims. In the claims, means-plus-function clauses, where used, are intended to cover the structures described herein as performing the recited function and not only structural equivalents but also equivalent structures. Therefore, it is to be understood that the foregoing is illustrative of the present invention and is not to be construed as limited to the specific embodiments disclosed, and that modifications to the disclosed embodiments, as well as other embodiments, are intended to be included within the scope of the appended claims. The invention is defined by the following claims, with equivalents of the claims to be included therein.
This application is a divisional of U.S. application Ser. No. 10/727,123, filed Dec. 2, 2003, the disclosure of which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2071215 | Petersen | Feb 1937 | A |
2826193 | Rentsch, Jr. | Nov 1965 | A |
3219031 | Rentsch, Jr. | Nov 1965 | A |
3455298 | Anstadt | Jul 1969 | A |
3461861 | Barkalow et al. | Aug 1969 | A |
3496932 | Johnson et al. | Feb 1970 | A |
3509899 | Hewson | May 1970 | A |
3613672 | Schiff | Oct 1971 | A |
3825015 | Berkovits | Jul 1974 | A |
3896797 | Bucur | Jul 1975 | A |
3995623 | Blake et al. | Dec 1976 | A |
4048990 | Goetz | Sep 1977 | A |
4192293 | Asrican | Mar 1980 | A |
4273114 | Barkalow et al. | Jun 1981 | A |
4355646 | Kallok et al. | Oct 1982 | A |
4365639 | Goldreyer | Dec 1982 | A |
4397306 | Weisfeldt et al. | Aug 1983 | A |
4424806 | Newman et al. | Jan 1984 | A |
4444195 | Gold | Apr 1984 | A |
4499907 | Kallok et al. | Feb 1985 | A |
4536893 | Parravicini | Aug 1985 | A |
4559946 | Mower | Dec 1985 | A |
4567901 | Harris | Feb 1986 | A |
4637397 | Jones et al. | Jan 1987 | A |
4643201 | Stokes | Feb 1987 | A |
4690134 | Snyders | Sep 1987 | A |
4693253 | Adams | Sep 1987 | A |
4708145 | Tacker, Jr. et al. | Nov 1987 | A |
4731076 | Noon et al. | Mar 1988 | A |
4800883 | Winstrom | Jan 1989 | A |
4850357 | Bach, Jr. | Jul 1989 | A |
4901725 | Nappholz et al. | Feb 1990 | A |
4928674 | Halperin et al. | May 1990 | A |
4928688 | Mower | May 1990 | A |
5107834 | Ideker et al. | Apr 1992 | A |
5165403 | Mehra | Nov 1992 | A |
5169381 | Snyders | Dec 1992 | A |
5184616 | Weiss | Feb 1993 | A |
5201808 | Steinhaus et al. | Apr 1993 | A |
5209229 | Gilli | May 1993 | A |
5224476 | Ideker et al. | Jul 1993 | A |
5230337 | Dahl et al. | Jul 1993 | A |
5235977 | Hirschberg et al. | Aug 1993 | A |
5235978 | Hirschberg et al. | Aug 1993 | A |
5239988 | Swanson et al. | Aug 1993 | A |
5251624 | Bocek et al. | Oct 1993 | A |
5256132 | Snyders | Oct 1993 | A |
5267559 | Jin et al. | Dec 1993 | A |
5269298 | Adams et al. | Dec 1993 | A |
5269319 | Schulte et al. | Dec 1993 | A |
5282836 | Kreyenhagen et al. | Feb 1994 | A |
5292338 | Bardy | Mar 1994 | A |
5295481 | Geeham | Mar 1994 | A |
5303702 | Bonnet et al. | Apr 1994 | A |
5304139 | Adams et al. | Apr 1994 | A |
5304218 | Alferness | Apr 1994 | A |
5312444 | Bocek et al. | May 1994 | A |
5313953 | Yomtov et al. | May 1994 | A |
5314430 | Bardy | May 1994 | A |
5324309 | Kallok | Jun 1994 | A |
5331966 | Bennett et al. | Jul 1994 | A |
5332400 | Alferness | Jul 1994 | A |
5344430 | Berg et al. | Sep 1994 | A |
5348021 | Adams et al. | Sep 1994 | A |
5350402 | Infinger et al. | Sep 1994 | A |
5366485 | Kroll et al. | Nov 1994 | A |
5366486 | Zipes et al. | Nov 1994 | A |
5385528 | Wilk | Jan 1995 | A |
5387233 | Alferness et al. | Feb 1995 | A |
5395373 | Ayers | Mar 1995 | A |
5403351 | Saksena | Apr 1995 | A |
5403354 | Adams et al. | Apr 1995 | A |
5405375 | Ayers et al. | Apr 1995 | A |
5411527 | Alt | May 1995 | A |
5423772 | Lurie et al. | Jun 1995 | A |
5431681 | Helland | Jul 1995 | A |
5431682 | Hedberg | Jul 1995 | A |
5431683 | Bowald et al. | Jul 1995 | A |
5433729 | Adams et al. | Jul 1995 | A |
5433730 | Alt | Jul 1995 | A |
5441519 | Sears | Aug 1995 | A |
5443491 | Snichelotto | Aug 1995 | A |
5447519 | Peterson | Sep 1995 | A |
5456706 | Pless et al. | Oct 1995 | A |
5464429 | Hedberg et al. | Nov 1995 | A |
5464432 | Infinger et al. | Nov 1995 | A |
5466221 | Zadini et al. | Nov 1995 | A |
5470348 | Neubauer et al. | Nov 1995 | A |
5476498 | Ayers | Dec 1995 | A |
5476499 | Hirschberg | Dec 1995 | A |
5484391 | Buckman, Jr. et al. | Jan 1996 | A |
5486199 | Kim et al. | Jan 1996 | A |
5487753 | MacCarter et al. | Jan 1996 | A |
5489293 | Pless et al. | Feb 1996 | A |
5496345 | Kieturakis et al. | Mar 1996 | A |
5514153 | Bonutti | May 1996 | A |
5522853 | Kroll | Jun 1996 | A |
5531764 | Adams et al. | Jul 1996 | A |
5540711 | Kieturakis et al. | Jul 1996 | A |
5554176 | Maddison et al. | Sep 1996 | A |
5560369 | McClure et al. | Oct 1996 | A |
5571074 | Buckman, Jr. et al. | Nov 1996 | A |
5573517 | Bonutti et al. | Nov 1996 | A |
5578064 | Prutchi | Nov 1996 | A |
5582580 | Buckman et al. | Dec 1996 | A |
5584865 | Hirschberg et al. | Dec 1996 | A |
5593418 | Mollenauer | Jan 1997 | A |
5601581 | Fogarty et al. | Feb 1997 | A |
5601589 | Fogarty et al. | Feb 1997 | A |
5601590 | Bonutti et al. | Feb 1997 | A |
5607443 | Kieturakis et al. | Mar 1997 | A |
5609621 | Bonner | Mar 1997 | A |
5618287 | Fogarty et al. | Apr 1997 | A |
5620471 | Duncan | Apr 1997 | A |
5624381 | Kieturakis | Apr 1997 | A |
5630789 | Schock et al. | May 1997 | A |
5653726 | Kieturakis | Aug 1997 | A |
5667479 | Kieturakis | Sep 1997 | A |
5667520 | Bonutti | Sep 1997 | A |
5683364 | Zadini et al. | Nov 1997 | A |
5683429 | Mehra | Nov 1997 | A |
5685826 | Bonutti | Nov 1997 | A |
5690668 | Fogarty et al. | Nov 1997 | A |
5694951 | Bonutti | Dec 1997 | A |
5697953 | Kroll et al. | Dec 1997 | A |
5702416 | Kieturakis et al. | Dec 1997 | A |
5702417 | Hermann | Dec 1997 | A |
5707390 | Bonutti | Jan 1998 | A |
5716325 | Bonutti | Feb 1998 | A |
5718718 | Kroll et al. | Feb 1998 | A |
5730748 | Fogarty et al. | Mar 1998 | A |
5730756 | Kieturakis et al. | Mar 1998 | A |
5772613 | Gelfand et al. | Jun 1998 | A |
5800469 | Nappholz | Sep 1998 | A |
5800470 | Stein et al. | Sep 1998 | A |
5861012 | Stroebel | Jan 1999 | A |
5978704 | Ideker et al. | Nov 1999 | A |
5978705 | KenKnight et al. | Nov 1999 | A |
5987354 | Cooper et al. | Nov 1999 | A |
6002962 | Huang et al. | Dec 1999 | A |
6006131 | Cooper et al. | Dec 1999 | A |
6059750 | Fogarty et al. | May 2000 | A |
6148230 | KenKnight | Nov 2000 | A |
6179793 | Rothman et al. | Jan 2001 | B1 |
6198968 | Prutchi et al. | Mar 2001 | B1 |
6200280 | Brenneman et al. | Mar 2001 | B1 |
6213960 | Sherman et al. | Apr 2001 | B1 |
6275730 | KenKnight et al. | Aug 2001 | B1 |
6285907 | Kramer et al. | Sep 2001 | B1 |
6287267 | Brenneman et al. | Sep 2001 | B1 |
6327500 | Cooper et al. | Dec 2001 | B1 |
6334070 | Nova et al. | Dec 2001 | B1 |
6371119 | Zadini et al. | Apr 2002 | B1 |
6374827 | Bowden et al. | Apr 2002 | B1 |
6388866 | Rorvick et al. | May 2002 | B1 |
6390996 | Halperin et al. | May 2002 | B1 |
6406444 | Brenneman et al. | Jun 2002 | B2 |
6503265 | Fogarty et al. | Jan 2003 | B1 |
20010027279 | Rothman et al. | Oct 2001 | A1 |
20020143278 | Bystrom et al. | Oct 2002 | A1 |
20040049118 | Ideker et al. | Mar 2004 | A1 |
20040172068 | Sullivan et al. | Sep 2004 | A1 |
Number | Date | Country |
---|---|---|
0095726 | Feb 1988 | EP |
0472 411 | Feb 1992 | EP |
0509773 | Apr 1992 | EP |
0554 208 | Aug 1993 | EP |
0 601 340 | Jun 1994 | EP |
0804938 | Nov 1997 | EP |
WO9623546 | Aug 1996 | WO |
WO 9701373 | Jan 1997 | WO |
WO9965561 | Dec 1999 | WO |
Entry |
---|
Allessie et al., “Regional control of atrial fibrillation by rapid pacing in onscious dogs,” Circulation 1991;84:1689-1697. |
Capucci et al., “Capture window in human atrial fibrillation: evidence of an excitable gap,” J Cardiovasc Electrophysiol 1999;10:319-327. |
Cooper et al., “Internal Cardioversion of Atrial Fibrillation in Sheep,” Atrial Fibrillation: Mechanisms and Therapeutic Strategies, (1994) pp. 325-332. |
Cooper et al., “Internal Cardioversion of Atrial Fibrillation in Sheep,” Circulation, vol. 87, No. 5, May 1993, pp. 1673-1685. |
U.S. Appl. No. 10/238,343, filed Sep. 10, 2002, Ideker et al. |
Daoud et al. “Response of Type I atrial fibrillation to atrial pacing in humans,” Circulation 1996;94:1036-1040. |
Feeser et al., “Strength-Duration and Probability of Success Curves for Defibrillation with Biphasic Waveforms,” Circulation, vol. 82, No. 6, Dec. 1990, pp. 2128-2141. |
Garcia-Calvo et al., “The effects of selective stellate ganglion manipulation on ventricular refractoriness and excitability,” PACE, 1992;15:1492-1503. |
Halperin et al., “A Preliminary Study of Cardiopulmonary Resuscitation by Circumferential Compression of the Chest with Use of a Pneumatic Vest,” The New England Journal of Medicine, Sep. 9, 1993, vol. 329:762-768. |
Huang et al., “Evolution of the organization of epicardial activation patterns during ventricular fibrillation,” J Cardiovasc Electrophysiol, 1998;9:1291-1304. |
KenKnight et al., “Regional capture of fibrillating ventricular myocardium: Evidence of an excitable gap,” Circ Res 1995;77:849-855. |
Kirchhof et al., “Regional entrainment of atrial fibrillation studied by high-resolution mapping in open-chest dogs,” Circulation 1993;88:736-749. |
Knisley et al., “Line stimulation parallel to myofibers enhances regional uniformity of transmembrane voltage changes in rabbit hearts,” Circ Res 1997;81:229-241. |
Kroll, Mark W., “A Minimal Model of the Monophasic Defibrillation Pulse,” PACE, vol. 16, Apr. 1993, Part I, pp. 769-777. |
Lammers, W. J.E.P. et al., The use of fibrillation cycle length to determine spatial dispersion in electrophysiological properties and to characterize the underlying mechanism of fibrillation, New Trends in Arrhythmias, vol. II, N. 1, Jan.-Mar. 1986, pp. 109-112. |
Lewalter et al., “The Low Intensity Treadmill Exercise” Protocol for Appropriate Rate Adaptive Programming of Minute Ventilation Controlled Pacemakers, (Jul. 1995) PACE, 18:1374-1387. |
Link, Mark S. Commotio cordis: sudden death deu to chest wall impact in sports. Heart. Feb. 1999, 81 (2): 109-10. |
Lok et al.; “Clinical Shock Tolerability and Effect of Different Right Atrial Electrode Locations on Efficacy of Low Energy Human Transvenous Atrial Defibrillation Using an Implantable Lead System”, JACC 30:5 (1997) 1324-1330. |
Lüderitz et al., “Nonpharmacologic Strategies for Treating Atrial Fibrillation,” The American Journal of—Cardiology, vol. 77, Jan. 25, 1996, pp. 45A-52A. |
Neri et al.; “Internal Cardioversion of Chronic Atrial Fibrillation in Patients”, PACE 20, (1997) 2237-2242. |
Opthof et al., “Dispersion of refracteries in canine ventricular myocardium: Effects of sympathetic stimulation,” Circ Res 1991;68:1204-1215. |
Prof. Dr. med. Eckhard Alt; “Letters to the Editor”, (1998) PACE 21 633-634. |
Province et al., “Effect of pulse train amplitude and waveform on ability to entrain fibrillating rabbit ventricle with epicardial pacing,” (1999) PACE, 22:A66 (Abstract). |
Qin, Hao et al., “Recurrence Patterns After Failed Defibrillation of Spontaneous Ventricular Fibrillation During Acute Ischemia,” Supplement to Journal of the American College of Cardiology, p. 3, Mar. 6, 2002, vol. 39, No. 5 Supplement A. |
Qin, Hao et al., “Difibrillation Efficacy for Spontaneous and electrically-Induced Ventricular Fibrillation During Acute Ischemia,” Supplement to Circulation Journal of the American Heart Association, #2125, 2000. |
Qin, Hao et al., “Impact of Myocardial Ischemia and Reperfusion on Ventricular Defibrillation Patterns, Energy Requirements, and Detection of Recovery,” (Circulation 2002;105:2537) Published online before print May 6, 2002, 10.1161/01.CIR.0000016702.86180.F6. |
Rogers et al., “A quantitative framework for analyzing epicardial activation patterns during ventricular fibrillation,” Ann Biomed Eng 1997; 25:749-760. |
Rogers et al., “Recurrent wavefront morphologies: a method for quantifying the complexity of epicardial activation patterns,” Ann Biomed Eng 1997; 25:761-768. |
Rollins et al., “Macintosh based programmable cardiac stimulatr,” J Am Coll Cardiol, 15:261A (1990) Abstract. |
Rozenberg et al., “Prehospital use of minimally invasive direct cardiac massage (MIDCM): a pilot study,” Resuscitation 50 (2001) 257262. |
Vander et al. “Human Physiology—The Mechanisms of Body Functio,”Jan. 1985 pp. 230-236. |
Wharton et al., “Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular defibrillation,” Circulation 1992; 85:1510-1523. |
Wright et al., “Cardiac Rhythm Management Laboratory: In Vivo Study Protocol, Internal Atrial Defibrillation in Sheep Using Sequential Biphasic Waveforms,” CRM Laboratory, University of Alabama—Birmingham Medical Center, Oct. 1995. |
PCT International Search Report, International Application No. PCT/US2004/039986 mailed Apr. 18, 2005. |
Number | Date | Country | |
---|---|---|---|
20100204623 A1 | Aug 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10727123 | Dec 2003 | US |
Child | 12766290 | US |